Founders Financial Alliance’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Founders Financial Alliance’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.2K	Hold	443	–	–	﹤0.01%	616
2026 Q1	$19.4K	Buy	+443	New	+$20.5K	﹤0.01%	580
2025 Q4	–	Sell	-531	Closed	-$20.6K	–	651
2025 Q3	$20.6K	Buy	+531	New	+$19.2K	﹤0.01%	561
2025 Q1	–	Sell	-536	Closed	-$20.8K	–	628
2024 Q4	$20.8K	Sell	536 -75	-12%	-$3.15K	0.01%	439
2024 Q3	$27.5K	Sell	611 -6	-1%	-$268	0.01%	432
2024 Q2	$25.8K	Sell	617 -31	-5%	-$1.3K	0.01%	422
2024 Q1	$29.5K	Hold	648	–	–	0.01%	416
2023 Q4	$30K	Hold	648	–	–	0.01%	375
2023 Q3	$26.4K	Hold	648	–	–	0.01%	365
2023 Q2	$31.4K	Sell	648 -43	-6%	-$2.15K	0.01%	380
2023 Q1	$34.5K	Sell	691 -1	-0.1%	-$51	0.02%	332
2022 Q4	$35K	Hold	692	–	–	0.02%	354
2022 Q3	$35K	Buy	+692	New	+$39K	0.02%	346
2022 Q2	–	Sell	-842	Closed	-$51K	–	520
2022 Q1	$51K	Sell	842 -94	-10%	-$5.93K	0.02%	321
2021 Q4	$74K	Hold	936	–	–	0.03%	323
2021 Q3	$83K	Hold	936	–	–	0.04%	291
2021 Q2	$93K	Hold	936	–	–	0.04%	301
2021 Q1	$84K	Buy	936 +395	+73%	+$39K	0.04%	286
2020 Q4	$51K	Buy	541 +75	+16%	+$6.28K	0.03%	293
2020 Q3	$34K	Buy	+466	New	+$33.4K	0.02%	455

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return

Founders Financial Alliance's GNOM Position: Q2 2026 in Review

Founders Financial Alliance held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q2 2026 at 443 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #616.

Founders Financial Alliance first reported a position in GNOM in Q3 2020 and has held it in 20 quarters since. The position peaked at $93K in Q2 2021. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

Founders Financial Alliance held 443 shares of Global X Genomics & Biotechnology ETF worth $25.2K as of Q2 2026.
Founders Financial Alliance left its Global X Genomics & Biotechnology ETF share count unchanged in Q2 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Founders Financial Alliance's portfolio in Q2 2026, its #616 holding.
Founders Financial Alliance first reported a position in Global X Genomics & Biotechnology ETF in Q3 2020 and has held it in 20 quarters since.
Founders Financial Alliance's Global X Genomics & Biotechnology ETF position peaked at $93K in Q2 2021.
48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Founders Financial Alliance's 13F filing for Q2 2026, filed 4 Aug 2026.